Is Wegovy taken for life, or does treatment eventually end?

You've lost weight on Wegovy, then wondered what happens if you stop

Picture this: a few months in, the scale has moved meaningfully, clothes fit differently and you feel better. Then someone asks whether you'll be on this injection forever, and the question lodges. It is one of the things our prescribers hear most often, and it deserves a straight answer rather than a vague reassurance.

The STEP 1 trial, published in the New England Journal of Medicine, followed adults on semaglutide 2.4mg for 68 weeks and recorded an average weight reduction of around 15%. A follow-on study then tracked what happened when participants switched to placebo: within 12 months of stopping, roughly two-thirds of the weight loss was regained on average. The researchers concluded this was consistent with obesity being a chronic, relapsing condition, the same framing the NHS and NICE use. That context matters, because it changes how you think about the question. You are not failing if weight returns; the biology of appetite regulation does not simply switch off because you stopped injecting.

None of this means you are committed to injections indefinitely the moment you start. It means the decision to stop, pause or continue warrants the same careful thought as the decision to begin. Our semaglutide information page covers the broader clinical picture if you want the background before that conversation.

What the NICE guidance actually says, and where private treatment fits

NICE's appraisal of semaglutide for weight management, TA875, recommends its use for a maximum of two years within a specialist weight management service on the NHS. That two-year ceiling applies to NHS-funded treatment; it does not mean the medicine is unsafe beyond that point, but it does reflect the evidence base at the time of appraisal and NHS resource constraints. NICE also says clinicians should consider stopping if weight loss is less than 5% after six months on the maintenance dose.

Private prescribing sits outside TA875's two-year rule, but that does not make it a free pass. A responsible private prescriber still reviews whether continuing is clinically appropriate, whether the benefits still outweigh any risks and whether your health goals are being met. At nume, every repeat prescription involves a fresh assessment by a named prescriber, not a form ticked automatically. Cost is a real factor in long-term treatment too; our Wegovy cost page sets out what private treatment involves financially, so you can plan honestly.

The licensed indication for Wegovy is weight management alongside a reduced-calorie diet and increased physical activity. It is not licensed as a permanent maintenance drug in the way some blood pressure medicines are, but there is also no licensed upper time limit in the private setting. If you are weighing up whether Wegovy is something you would need for life, that question is addressed in detail on its own page. Duration is a clinical conversation.

What actually happens to your body when Wegovy stops

Semaglutide works by activating GLP-1 receptors involved in appetite signalling and how quickly food moves through your stomach. While it is active, hunger signals are dampened and you feel satisfied on smaller amounts of food. Stop taking it, and those effects fade as the medicine clears your system over a few weeks. Appetite tends to return to its previous baseline, which for many people with obesity is biologically higher than average, driven by hormones rather than habit or willpower.

This is why the regain seen in trials happens relatively quickly: the underlying physiology reasserts itself. Some people find that the lifestyle changes they built during treatment (different eating patterns, more movement, a better sense of hunger cues) provide a meaningful buffer. Others find the return of appetite overwhelming and regain weight despite their best efforts. Both outcomes are real, and neither reflects a personal failing.

If you are thinking about how Wegovy is taken through each phase of treatment, that detail is covered separately. Understanding which Wegovy doses are available and how the milligram steps work can also help frame what a long-term treatment plan might look like. The broader question of long-term use is worth raising with your prescriber well before you reach a decision point, not on the day you run out.

Having the long-term conversation before it becomes urgent

The most useful thing anyone can do is raise the duration question early, not at the point of panic. A good prescriber will map out what continued treatment looks like, what stopping might involve for your specific situation and what support exists either way. Lifestyle factors, your starting weight, any underlying conditions and how much weight you have maintained all feed into that picture.

We know this can feel daunting, especially for people who have tried other routes and found them unsustaining. There is no judgement attached to needing ongoing support for a chronic condition, most chronic conditions work exactly this way. If you want to explore what Wegovy involves from the beginning, or if you are already mid-treatment and want a prescriber to review your options, a free consultation is the right starting point. Our clinical team, including our independent prescribers, work through these decisions with patients regularly. When you feel ready, you can start your free consultation and get a personal clinical assessment the same day.